Neural Alteration Response to Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Depressed Patients
NCT ID: NCT03592446
Last Updated: 2018-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2018-09-01
2020-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of taVNS on Motivation in MDD With Anhedonia
NCT06026904
Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression
NCT04153812
Vagus Nerve Stimulation: Integration of Behavior and Cardiac Modulation
NCT04467164
tVNS, Motivation, and Insulin Sensitivity
NCT07198100
Effects of Respiratory-Gated Transcutaneous Vagal Nerve Stimulation in Major Depression (Phase 1)
NCT04607226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active-raVNS
Transcutaneous electrical vagus nerve stimulation at ear.
Transcutaneous electrical vagus nerve stimulation
All subjects receive electrical VNS stimulation at cymba conchae.
Sham-raVNS
Sham vagus nerve stimulation at ear.
Sham vagus nerve stimulation
All subjects receive electrical stimulation at earlobe.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous electrical vagus nerve stimulation
All subjects receive electrical VNS stimulation at cymba conchae.
Sham vagus nerve stimulation
All subjects receive electrical stimulation at earlobe.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* without taking anti-depressive medication or other psychiatric medications 2 weeks before the experiment;
* Patient has exhibited symptoms for at least 2 months, but no longer than 2 years.
Exclusion Criteria
* With other severe organic diseases, such as severe heart disease, kidney failure etc;
* disagree with the consent form.
* Cannot receive MRI scan.
15 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xidian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
81471812
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.